checkpoint inhibitors Archives - Page 17 of 24

Meet CRI’s New CEO Alicia Zhou, PhD

Why CRI
- Our Purpose
- Our Approach
- Our Leadership
- About CRI
- Resources
  - Events
  - Blog
  - Media Room
  - Annual Reports
  - FAQs
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Immunotherapy
- Overview
  - Immunotherapy at a Glance
  - Immunotherapy In-Depth
- Resource Center
- Immunotherapy Stories
  - Patients
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Who We Serve
- Scientists
- Patients
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Take Action
- Donate
- Fundraise
- Participate
- Become a Partner
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW

Why CRI
- Our Purpose
- Our Approach
- Our Leadership
- About CRI
- Resources
  - Events
  - Blog
  - Media Room
  - Annual Reports
  - FAQs
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Immunotherapy
- Overview
  - Immunotherapy at a Glance
  - Immunotherapy In-Depth
- Resource Center
- Immunotherapy Stories
  - Patients
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Who We Serve
- Scientists
- Patients
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Take Action
- Donate
- Fundraise
- Participate
- Become a Partner
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW

Filter stories by:

AACR18 Day 3 Update

April 17, 2018December 14, 2022 Arthur N. Brodsky, PhD

Immunotherapy Combination Approved for First-Line Kidney Cancer Treatment

April 16, 2018October 31, 2024 Arthur N. Brodsky, PhD

AACR18 Day 2 Update

April 16, 2018October 31, 2024 viewstream-admin

Preview Immunotherapy Highlights from AACR 2018 Annual Meeting

April 12, 2018October 31, 2024 Arthur N. Brodsky, PhD

Durvalumab Becomes First Immunotherapy Approved for Stage III Lung Cancer

February 20, 2018December 14, 2022 Arthur N. Brodsky, PhD

2018 Immuno-Oncology 360° Conference

February 12, 2018December 14, 2022 Arthur N. Brodsky, PhD

1 … 15 16 17 18 19 … 24

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.